F140724H |
UHPLC separation of hydroxychloroquine and chloroquine |
Drugs, Metabolites |
Hydroxychloroquine sulfate
Chloroquine phosphate |
YMC-Triart C18 |
TA12SP9-0502PT |
B220824A |
Argatroban Hydrate (The Japanese Pharmacopoeia) |
Drugs, Metabolites |
Methyl benzoate (I.S.)
Argatroban hydrate |
YMC-Triart C18 |
TA12S05-2546PTH |
B220927C |
Argatroban Hydrate (The Japanese Pharmacopoeia) |
Drugs, Metabolites |
Argatroban hydrate |
YMC-Pack Pro C18 RS |
RS08S05-1506WT |
F140618A |
Warfarin |
Drugs, Metabolites Optical isomers |
Warfarin |
CHIRAL ART Cellulose-SB |
KSB99S05-2546WT |
AB210510A |
Polaprezinc (The Japanese Pharmacopoeia) |
Drugs, Metabolites |
L-Histidine
L-Carnosine |
YMC-Triart C18 |
TA12S05-1546PTH |
AB210427A |
Polaprezinc Granules (The Japanese Pharmacopoeia) |
Drugs, Metabolites |
4-Aminoacetophenone (I.S.)
L-Carnosine |
YMC-Triart C18 |
TA12S05-1546PTH |
F150216B |
Lansoprazole |
Drugs, Metabolites Optical isomers |
Lansoprazole |
CHIRAL ART Amylose-SA |
KSA99S05-2546WT |
C150109E |
Lansoprazole(JP draft;Assay) |
Drugs, Metabolites |
Lansoprazole
4'-Ethoxyacetophenone (I.S.) |
YMC-Triart C18 |
TA12S05-2546PTH |
C150304A |
Lansoprazole(JP draft;Related substances) |
Drugs, Metabolites |
Lansoprazole |
YMC-Triart C18 |
TA12S05-1546PTH |
C150304B |
Lansoprazole delayed-release orally disintegration tablets(JP draft;Related substances) |
Drugs, Metabolites |
Lansoprazole |
YMC-Triart C18 |
TA12S05-1546PTH |
F150316A |
Rabeprazole |
Drugs, Metabolites Optical isomers |
Rabeprazole |
CHIRAL ART Cellulose-SC |
KSC99S05-2546WT |
AB190727A |
Crospovidone (The Japanese Pharmacopoeia) |
Drugs, Metabolites |
1-Vinyl-2-pyrrolidone
Vinyl acetate |
YMC-Triart C18 |
TA12S05-2504WT |
AB190727A |
Crospovidone (The Japanese Pharmacopoeia) |
Drugs, Metabolites |
1-Vinyl-2-pyrrolidone
Vinyl acetate |
YMC-Triart C18 Guard Cartridge Columns |
TA12S05-0204GC |
AB190726A |
Copovidone (The Japanese Pharmacopoeia) |
Drugs, Metabolites |
1-Vinyl-2-pyrrolidone
Vinyl acetate |
YMC-Triart C18 |
TA12S05-H346PTH |
AB190726A |
Copovidone (The Japanese Pharmacopoeia) |
Drugs, Metabolites |
1-Vinyl-2-pyrrolidone
Vinyl acetate |
YMC-Triart C18 |
TA12S05-2504WT |
B220926A |
Hypromellose Phthalate |
Drugs, Metabolites |
Phthalic acid |
YMC-Triart Prep C18-S |
TAS12S07-2546WT |
AB190719A |
Poly (vinyl acetate) dispersion 30 percent (Japanese Pharmaceutical Excipients) |
Drugs, Metabolites |
1-Vinyl-2-pyrrolidone
Vinyl acetate |
YMC-Triart C18 |
TA12S05-2504WT |
AB190821C |
Polyvinyl Alcohol・Polyethylene Glycol Graft Copolymer (Japanese Pharmaceutical Excipients) |
Drugs, Metabolites |
1-Vinyl-2-pyrrolidone
Vinyl acetate |
YMC-Pack ODS-AL |
AL12S05-2504WT |
F150319A |
Ofloxacin(Levofloxacin) |
Antibiotics Optical isomers |
Ofloxacin
Levofloxacin |
CHIRAL ART Cellulose-SC |
KSC99S05-2546WT |
K940614B |
Antibacterial agents |
Antibiotics |
Olaquindox
Carbadox
Thiamphenicol
Sulfamerazine
Sulfadimidine
Sulfamonomethoxine
Furazolidone
Oxolinic acid
Sulfaquinoxaline
Sulfadimethoxine
Nalidixic acid
Piromidic acid |
YMC-Pack ODS-A |
AA12S05-2546WT |